Skip to content

Comparison of Epidural injection of local anesthetic with or without steroid injection for low back and leg pain.

EVALUATION OF THE EFFECTIVENESS OF PARASAGITTAL INTERLAMINAR LUMBAR EPIDURAL INJECTIONS: COMPARISON OF LOCAL ANESTHETICS WITH OR WITHOUT STEROID IN MANAGEMENT OF CHRONIC BACKACHE WITH LUMBO-SACRAL RADICULAR PAIN: A RANDOMIZED, DOUBLE- BLIND TRIAL.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/04/004572
Enrollment
68
Registered
2014-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic low back pain with radicular pain showing than 50 on VAS

Interventions

Intervention1: Lignocaine Injection group (group L): Epidural injection of 10 ml of 0.5% lignocaine through parasaggital approach Control Intervention1: Ligocaine and steroid injection group (group LS

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: chronic low back pain with with unilateral lumbosacral radicular pain of at least one month having a pain score of >50, as assessed by visual analog scale (VAS,0-100 points)

Exclusion criteria

Exclusion criteria: Patients were excluded if they had any clinically significant or unstable medical or psychiatric illnesses, history of previous surgery on the lumbar spine and spinal canal stenosis, unstable neurological deficits and cauda equine syndrome. Those who have received lumbar epidural steroids injections in the past, allergic to corticosteroids, taking anticoagulants or bleeding diathesis or altered coagulation, taking systematic corticosteroids, pregnant and lactating women patients

Design outcomes

Primary

MeasureTime frame
Pain relief of 50% as assessed by VASTimepoint: At 3 months

Secondary

MeasureTime frame
pain relief using VAS, functional assessment using modified ODQ ,treatment emergent adverse drug reactions Timepoint: 0.5, 1, 2, 3, 4, 5 and 6 months post-intervention

Countries

India

Contacts

Public ContactDr Babita Ghai

Post Graduate Institute of Medical Education and Research

kush.mmc@gmail.com08872869658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 4, 2026